TCL Archive 60 Minutes To Air Segment On The “Deception at Duke” By Cancer History Project February 10, 2012
TCL Archive The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage By Cancer History Project February 3, 2012
TCL Archive FASEB Delivers Its Recommendations For Federal Research Funding in 2013 By Cancer History Project February 3, 2012
TCL Archive From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas By Cancer History Project January 27, 2012
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent By Cancer History Project January 27, 2012
TCL Archive FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials By Cancer History Project January 27, 2012
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial By Cancer History Project January 27, 2012
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements By Cancer History Project January 27, 2012
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
